# TSPO

## Overview
The TSPO gene encodes the translocator protein, a transmembrane protein primarily located on the outer mitochondrial membrane. This protein is involved in a variety of cellular processes, including the transport of cholesterol into mitochondria, which is crucial for steroid hormone biosynthesis (Papadopoulos2018Translocator). TSPO is characterized by a conserved five transmembrane α-helical structure that facilitates high-affinity ligand binding, including cholesterol and other radioligands (Jaipuria2017Cholesterolmediated). Beyond its role in steroidogenesis, TSPO is implicated in mitochondrial bioenergetics, cellular metabolism, and the regulation of reactive oxygen species (ROS) production, which are essential for maintaining cellular homeostasis and protecting against oxidative damage (Nutma2021Cellular; El2022The). In the central nervous system, TSPO is predominantly expressed in glial cells and is involved in neurosteroid formation, with potential implications for neuropsychiatric and neurodegenerative disorders (El2022The). Despite its critical roles, recent studies suggest that TSPO may not be essential for steroidogenesis, indicating potential compensatory mechanisms in its absence (Tu2014Peripheral).

## Structure
The translocator protein (TSPO) is a mitochondrial membrane protein characterized by a conserved five transmembrane α-helical structure. These helices form a compact, hydrophobic pocket that facilitates high-affinity ligand binding, including cholesterol and other radioligands (Xia2019A; Jaipuria2017Cholesterolmediated). The protein's secondary structure is well-defined, with the transmembrane helices tightly packed, and specific motifs such as the CRAC motif at the C-terminus playing a crucial role in cholesterol binding (Jaipuria2017Cholesterolmediated).

TSPO can exist in different oligomeric states, transitioning between monomeric and dimeric forms. This oligomerization is influenced by cholesterol binding, which promotes monomerization through an allosteric mechanism involving the GxxxG motif in transmembrane helix III (Jaipuria2017Cholesterolmediated). The protein's quaternary structure is further characterized by its ability to form dimers, with the dimer interface being primarily hydrophobic and involving specific motifs such as W95XP97XF99 (Zeng2018Structural).

TSPO is subject to post-translational modifications, including potential phosphorylation, which may affect its function and interactions. The protein also exhibits splice variant isoforms, contributing to its functional diversity (Jaipuria2017Cholesterolmediated).

## Function
The translocator protein (TSPO) is a multifunctional protein located on the outer mitochondrial membrane, playing a crucial role in various cellular processes. It is primarily involved in the transport of cholesterol into mitochondria, which is essential for steroid hormone biosynthesis. This process is particularly significant in steroidogenic tissues such as the adrenal glands and gonads, where TSPO facilitates the conversion of cholesterol to pregnenolone, the precursor of steroid hormones (Nutma2021Cellular; Papadopoulos2018Translocator).

TSPO is also implicated in mitochondrial bioenergetics and cellular metabolism. It influences mitochondrial membrane potential and oxygen-mediated metabolism, affecting processes such as apoptosis, cell proliferation, and immunological responses (Nutma2021Cellular; Betlazar2020The). TSPO interacts with the voltage-dependent anion channel 1 (VDAC1) and regulates reactive oxygen species (ROS) production, which is crucial for maintaining cellular homeostasis and protecting against oxidative damage (El2022The).

In the central nervous system, TSPO is predominantly expressed in glial cells and is involved in neurosteroid formation, which may have implications for neuropsychiatric and neurodegenerative disorders (Papadopoulos2018Translocator; El2022The). Despite its critical roles, recent studies suggest that TSPO may not be essential for steroidogenesis, indicating potential compensatory mechanisms in its absence (Tu2014Peripheral).

## Clinical Significance
Mutations and polymorphisms in the TSPO gene have been linked to various diseases and conditions. The A147T and R162H mutations in TSPO are associated with significant protein degradation and reduced stability, impacting cholesterol binding and pregnenolone synthesis. These mutations are located in highly conserved regions of the protein, which are critical for its function, and have been linked to mood disorders and neuropsychiatric conditions (Milenkovic2018Effects).

The rs6971 polymorphism, resulting in an Ala147Thr substitution, affects TSPO's binding affinity for ligands and has been associated with psychiatric disorders, including anxiety and bipolar disorders. This polymorphism also impacts steroid synthesis by reducing the response to ACTH treatment, leading to dysregulated cortisol rhythms (Nutma2021Cellular; Owen2017TSPO).

In glioblastoma (GBM) patients, the rs6971 polymorphism is linked to worse survival outcomes, particularly in males. The presence of the G allele in this polymorphism is associated with shorter overall and progression-free survival times, suggesting its potential as a prognostic marker in GBM (Troike2021The). TSPO expression is also correlated with glioma malignancy and varies by GBM subtype (Troike2021The).

## Interactions
The translocator protein (TSPO) is involved in various interactions with other proteins, particularly in the context of mitochondrial and cellular functions. TSPO interacts with components of the NADPH oxidase complex, specifically the NOX2 subunits gp91 phox and p22 phox, in microglia. This interaction is thought to facilitate the transfer of heme from mitochondria to gp91 phox in the endoplasmic reticulum, potentially regulating NOX2 levels and reactive oxygen species (ROS) production (Loth2020A). TSPO also colocalizes with the voltage-dependent anion channel (VDAC) in microglia, suggesting a role in mitochondrial-associated endoplasmic reticulum membrane (MAM) interactions (Loth2020A).

TSPO's interaction with NADPH oxidase is implicated in the regulation of ROS production, which is crucial for microglial activation and function (Betlazar2020The). The protein is also involved in the formation of a protein complex with TMEM97, which may be required for Sigma-2 receptor activity (Thejer2023Sigma2). These interactions highlight TSPO's role in cellular bioenergetics, immune responses, and potential involvement in neurodegenerative processes (Loth2020A; Betlazar2020The).


## References


[1. (Troike2021The) Katie M. Troike, Arlet M. Acanda de la Rocha, Tyler J. Alban, Matthew M. Grabowski, Balint Otvos, Gino Cioffi, Kristin A. Waite, Jill S. Barnholtz Sloan, Justin D. Lathia, Tomás R. Guilarte, and Diana J. Azzam. The translocator protein (tspo) genetic polymorphism a147t is associated with worse survival in male glioblastoma patients. Cancers, 13(18):4525, September 2021. URL: http://dx.doi.org/10.3390/cancers13184525, doi:10.3390/cancers13184525. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers13184525)

[2. (Zeng2018Structural) Juan Zeng, Riccardo Guareschi, Mangesh Damre, Ruyin Cao, Achim Kless, Bernd Neumaier, Andreas Bauer, Alejandro Giorgetti, Paolo Carloni, and Giulia Rossetti. Structural prediction of the dimeric form of the mammalian translocator membrane protein tspo: a key target for brain diagnostics. International Journal of Molecular Sciences, 19(9):2588, August 2018. URL: http://dx.doi.org/10.3390/ijms19092588, doi:10.3390/ijms19092588. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms19092588)

[3. (Nutma2021Cellular) Erik Nutma, Kelly Ceyzériat, Sandra Amor, Stergios Tsartsalis, Philippe Millet, David R. Owen, Vassilios Papadopoulos, and Benjamin B. Tournier. Cellular sources of tspo expression in healthy and diseased brain. European Journal of Nuclear Medicine and Molecular Imaging, 49(1):146–163, January 2021. URL: http://dx.doi.org/10.1007/s00259-020-05166-2, doi:10.1007/s00259-020-05166-2. This article has 95 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1007/s00259-020-05166-2)

[4. (Tu2014Peripheral) Lan N. Tu, Kanako Morohaku, Pulak R. Manna, Susanne H. Pelton, W. Ronald Butler, Douglas M. Stocco, and Vimal Selvaraj. Peripheral benzodiazepine receptor/translocator protein global knock-out mice are viable with no effects on steroid hormone biosynthesis. Journal of Biological Chemistry, 289(40):27444–27454, October 2014. URL: http://dx.doi.org/10.1074/jbc.M114.578286, doi:10.1074/jbc.m114.578286. This article has 246 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M114.578286)

[5. (Xia2019A) Yan Xia, Kaitlyn Ledwitch, Georg Kuenze, Amanda Duran, Jun Li, Charles R. Sanders, Charles Manning, and Jens Meiler. A unified structural model of the mammalian translocator protein (tspo). Journal of Biomolecular NMR, 73(6–7):347–364, June 2019. URL: http://dx.doi.org/10.1007/s10858-019-00257-1, doi:10.1007/s10858-019-00257-1. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10858-019-00257-1)

[6. (Thejer2023Sigma2) Bashar M. Thejer, Vittoria Infantino, Anna Santarsiero, Ilaria Pappalardo, Francesca S. Abatematteo, Sarah Teakel, Ashleigh Van Oosterum, Robert H. Mach, Nunzio Denora, Byung Chul Lee, Nicoletta Resta, Rosanna Bagnulo, Mauro Niso, Marialessandra Contino, Bianca Montsch, Petra Heffeter, Carmen Abate, and Michael A. Cahill. Sigma-2 receptor ligand binding modulates association between tspo and tmem97. International Journal of Molecular Sciences, 24(7):6381, March 2023. URL: http://dx.doi.org/10.3390/ijms24076381, doi:10.3390/ijms24076381. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms24076381)

[7. (Owen2017TSPO) David R. Owen, Jinjiang Fan, Enrico Campioli, Sathvika Venugopal, Andrew Midzak, Edward Daly, Aline Harlay, Leeyah Issop, Vincenzo Libri, Dimitra Kalogiannopoulou, Eduardo Oliver, Enrique Gallego-Colon, Alessandro Colasanti, Les Huson, Eugenii A. Rabiner, Puvan Suppiah, Charles Essagian, Paul M. Matthews, and Vassilios Papadopoulos. Tspo mutations in rats and a human polymorphism impair the rate of steroid synthesis. Biochemical Journal, 474(23):3985–3999, November 2017. URL: http://dx.doi.org/10.1042/bcj20170648, doi:10.1042/bcj20170648. This article has 81 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bcj20170648)

[8. (El2022The) Léa El Chemali, Yvette Akwa, and Liliane Massaad-Massade. The mitochondrial translocator protein (tspo): a key multifunctional molecule in the nervous system. Biochemical Journal, 479(13):1455–1466, July 2022. URL: http://dx.doi.org/10.1042/bcj20220050, doi:10.1042/bcj20220050. This article has 9 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bcj20220050)

[9. (Papadopoulos2018Translocator) V. Papadopoulos, J. Fan, and B. Zirkin. Translocator protein (18 kda): an update on its function in steroidogenesis. Journal of Neuroendocrinology, February 2018. URL: http://dx.doi.org/10.1111/jne.12500, doi:10.1111/jne.12500. This article has 81 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/jne.12500)

[10. (Loth2020A) Meredith K. Loth, Sara R. Guariglia, Diane B. Re, Juan Perez, Vanessa Nunes de Paiva, Jennifer L. Dziedzic, Jeremy W. Chambers, Diana J. Azzam, and Tomás R. Guilarte. A novel interaction of translocator protein 18 kda (tspo) with nadph oxidase in microglia. Molecular Neurobiology, 57(11):4467–4487, August 2020. URL: http://dx.doi.org/10.1007/s12035-020-02042-w, doi:10.1007/s12035-020-02042-w. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12035-020-02042-w)

[11. (Milenkovic2018Effects) Vladimir M. Milenkovic, Stefanie Bader, Daniel Sudria-Lopez, Ramona Siebert, Caroline Brandl, Caroline Nothdurfter, Bernhard H. F. Weber, Rainer Rupprecht, and Christian H. Wetzel. Effects of genetic variants in the tspo gene on protein structure and stability. PLOS ONE, 13(4):e0195627, April 2018. URL: http://dx.doi.org/10.1371/journal.pone.0195627, doi:10.1371/journal.pone.0195627. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0195627)

[12. (Jaipuria2017Cholesterolmediated) Garima Jaipuria, Andrei Leonov, Karin Giller, Suresh Kumar Vasa, Łukasz Jaremko, Mariusz Jaremko, Rasmus Linser, Stefan Becker, and Markus Zweckstetter. Cholesterol-mediated allosteric regulation of the mitochondrial translocator protein structure. Nature Communications, March 2017. URL: http://dx.doi.org/10.1038/ncomms14893, doi:10.1038/ncomms14893. This article has 67 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncomms14893)

[13. (Betlazar2020The) Calina Betlazar, Ryan J. Middleton, Richard Banati, and Guo-Jun Liu. The translocator protein (tspo) in mitochondrial bioenergetics and immune processes. Cells, 9(2):512, February 2020. URL: http://dx.doi.org/10.3390/cells9020512, doi:10.3390/cells9020512. This article has 68 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells9020512)